Polypharmacy and Comorbidity Are Associated with a Lower Early Virologic Response in Hepatitis C Patients Treated with First Generation Protease Inhibitor Triple Therapy: A Preliminary Analysis

Author： Juneja Manie   Euliano Rebekah   Satoskar Rohit   Lewis James  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.58, Iss.11, 2013-11, pp. : 3348-3358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy

By Gelderblom Huub   Zaaijer Hans   Dijkgraaf Marcel   Van Der Meer Jan   Weegink Christine   Jansen Peter   Beld Marcel   Reesink Henk  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 7, 2008-01 ,pp. : 857-869

Informa Healthcare

Access to resources Recommend Favorite

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy

By Graham Camilla S.   Lontok Erik   Mani Nina   Harrington Patrick R.   Miller Veronica  

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1466-1470

Oxford University Press

Access to resources Recommend Favorite

Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy

By Ko Soon Young   Choe Won Hyeok   Kwon So Young   Kim Jeong Han   Seo Jung Woong   Kim Kyun-Hwan   Lee Chang Hong  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 11, 2012-11 ,pp. : 1362-1367

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon plus ribavirin over two years may be successful in patients with chronic hepatitis C and a very slow virologic response

By Ordubadi Parnaz   Gschwantler Michael  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 9, 2009-09 ,pp. : 1150-1151

Informa Healthcare

Access to resources Recommend Favorite